A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019. J. Cell Biol. https://doi.org/10.1083/jcb. 201902048) surprisingly show that the AKT-suppressing phosphatase PHLPP2 promotes disease progression in the context of dual PTEN and p53 loss by increasing MYC stability.

Cite

CITATION STYLE

APA

Toivanen, R., & Furic, L. (2019, June 3). A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer. Journal of Cell Biology. Rockefeller University Press. https://doi.org/10.1083/JCB.201904119

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free